AZRIELI GROUP LTD (AZRG)
Periodic and annual report for 2025
Innate Pharma S.A. (IPHA)
Innate Pharma - Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results
Molecular Partners AG (MOLN)
Molecular Partners Presents New Preclinical Data HighlightingRadio-DARPins’ Amenability to Multiple Isotopes
Innate Pharma S.A. (IPHA)
Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results
MOLECULAR PARTNERS AG (MOLN)
Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins’ Amenability to Multiple Isotopes
SHAPIR ENGINEERING AND INDUSTRY LTD (SPEN)
The company’s liabilities as of 31.12.25, by maturity dates
SHAPIR ENGINEERING AND INDUSTRY LTD (SPEN)
Periodic and annual report for 2025
LEXINFINTECH HOLDINGS LTD. (LX)
LexinFintech Holdings Ltd. Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
Immutep Limited (IMMP)
TACTI-004 Phase III and IMP761 Phase I Updates
Reviva Pharmaceuticals Holdings Inc. (RVPHW)
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering